Home
Stock screener
Insider screener
Rankings
Watchlist
Sign in
Create account
Stocks
·
Health care
· Pharmaceutical Preparations
VSTM
Verastem, Inc.
VSTM
Clue Score
56
United States
Fiscal year ends December
CIK 0001526119
Results filed 14 Oct 2026
Add to watchlist
Overview
Financials
Insiders
Summary
By person
Transactions
What the insiders did
Scheduled selling only
1 month
12 months
120 months
By person
13 insiders · 32 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Dan Paterson
President and CEO
—
$835.41K
(22)
scheduled
−$835.41K
651,413
0.7193%
$6.25M
−18.1%
Michael Kauffman
President of Development
—
$85.50K
(1)
scheduled
−$85.50K
8,666
0.0096%
$83.19K
−2.4%
Daniel Calkins
Chief Financial Officer
—
$74.75K
(6)
scheduled
−$74.75K
123,781
0.1367%
$1.19M
−13.4%
Paul A. Bunn
Director
—
$62.50K
(1)
scheduled
−$62.50K
44,333
0.0490%
$425.60K
+432.0%
Brian M Stuglik
Director
—
$5.41K
(1)
scheduled
−$5.41K
137,147
0.1514%
$1.32M
+42.7%
Robert E. Gagnon
Director
—
$2.59K
(1)
scheduled
−$2.59K
41,678
0.0460%
$400.11K
+19.4%
Michael P Bailey
Director
—
—
—
108,000
0.1193%
$1.04M
—
Eric K Rowinsky
Director
—
—
—
52,666
0.0582%
$505.59K
+532.0%
Anil Kapur
Director
—
—
—
52,666
0.0582%
$505.59K
+532.0%
John Johnson
Director
—
—
—
52,666
0.0582%
$505.59K
+532.0%
Michelle Robertson
Director
—
—
—
52,666
0.0582%
$505.59K
+532.0%
Karin Anna Tollefson
Director
—
—
—
52,666
0.0582%
$505.59K
+532.0%
Matthew Ros
Chief Operating Officer
—
—
—
50,000
0.0552%
$480.00K
—